We use essential cookies (authentication, your saved goals/stack) by default. With your permission we’ll also enable privacy-respecting analytics (Vercel Web Analytics, anonymous load-time metrics) and error-replay diagnostics (Sentry — DOM snapshots only when an error fires) so we can fix bugs faster. Learn more about cookies
Polyhydroxy Acids (gluconolactone, lactobionic acid)
A gentler, next-generation family of exfoliating acids (gluconolactone, lactobionic acid) applied to the skin — a cosmetic, not ingested. Because PHA molecules are larger than AHAs like glycolic acid, they penetrate more slowly and irritate less, while adding humectant and antioxidant properties. The honest framing: in head-to-head trials PHAs deliver anti-aging benefits comparable to AHAs with notably better tolerability — their real, evidence-backed niche is gentleness for sensitive and rosacea-prone skin. But the efficacy evidence is thin, older (mostly 2004–2010), and heavily industry-originated; there are no large modern independent RCTs, and effects are modest and roughly match or slightly trail AHAs.
Topical cosmetic ingredient — not a dietary supplement
Polyhydroxy Acids (PHA) is a topical cosmetic ingredient, not a supplement you take internally and not a drug. It is sold legally in skincare products to affect the appearance of skin (such as wrinkles). The evidence below comes mostly from small, often industry-funded studies of topical application, so treat the effect sizes cautiously. This page is for transparency and education, not a recommendation.
What the evidence says
Most Polyhydroxy Acids (PHA) studies are mechanism or observational rather than RCTs that measure a clinical effect — keep findings provisional.
Most evidence is from mixed-quality randomised trials published 1997–2023 with a typical study size of 77 participants.
Based on 9 studies · 4 RCTs · 77 total participants
Confidence
Moderate confidenceBy outcome
Coherent mechanism (gentler exfoliation, humectant, antioxidant/barrier acidification) and head-to-head trials showing anti-aging comparable to AHAs with better tolerability — but the efficacy evidence is thin, older (2004-2010), heavily industry-originated, with no large modern independent RCTs and modest effects that match or slightly trail AHAs.
Polyhydroxy acids (PHAs) — chiefly gluconolactone and the bionic acid lactobionic acid — are a 'next-generation' class of exfoliating acids designed to deliver alpha-hydroxy-acid-like benefits with less irritation. This entry covers TOPICAL cosmetic use.
Their defining feature is molecular size: PHAs are larger (and lactobionic acid is a disaccharide derivative) so they penetrate the stratum corneum more slowly and gently than glycolic acid, and they add humectant, metal-chelating, and antioxidant properties.
The mechanism is reasonably characterized: gluconolactone provided up to ~50% protection against UV-induced changes in an in-vitro photoaging model without increasing sunburn cells in human skin (Bernstein et al., 2004), and an independent preclinical study showed PHAs acidify the stratum corneum to improve barrier lipid processing and corneodesmosome integrity (Hachem et al., 2010).
On efficacy, the key controlled trial (Edison et al., 2004) found a gluconolactone (PHA) regimen produced anti-aging benefits comparable to a glycolic acid (AHA) regimen on silicone replicas, clinical grading, and pinch recoil — with significantly less stinging and burning; AHA modestly beat PHA on only 2 of the measured endpoints.
An independent bioengineering trial (Tasic-Kostov et al., 2010; n=77) found lactobionic acid outperformed glycolic acid on tolerability with no barrier impairment.
The honest caveats: the pivotal efficacy trial and a supporting review share NeoStrata (industry) authorship, an independent FDA/NIH review notes hydroxy-acid mechanisms 'still require more clarification,' samples are small (n≈24-77), the evidence clusters in 2004-2010, and there are no large modern independent RCTs with hard photoaging endpoints.
So the honest summary: PHAs are a well-tolerated, gentler alternative to AHAs with comparable (not superior) modest anti-aging effects and a genuine niche in sensitive/rosacea-prone skin, on a thin and partly industry-originated evidence base. None of this is a health claim.
It is listed under Beauty & Appearance so it is discoverable, but is sandboxed out of ingestible-supplement stacks and the schedule optimizer; it carries a cosmetic badge and a topical-only disclaimer.
PHAs (gluconolactone, lactobionic acid) are larger molecules than AHAs, so they penetrate the stratum corneum more slowly and exfoliate with less irritation. Independent work shows they acidify the stratum corneum to improve barrier-lipid processing and corneodesmosome integrity.
PHAs are also humectants and metal chelators with antioxidant activity; gluconolactone provided up to ~50% protection against UV-induced changes in an in-vitro photoaging model — properties that distinguish them from simple AHA exfoliation and support the sensitive-skin niche.
Topical PHAs have minimal absorption and are generally considered low-concern; discuss your routine with a clinician.
Often the preferred exfoliating acid here — lower irritation with no barrier impairment in studies.
AHAs may work a bit faster; PHAs trade a little potency for gentleness.
PHAs are gentler but still exfoliating; combining with other acids/retinoids can add irritation. Introduce one at a time. Not a systemic interaction — they are not ingested.
Tip: Generally gentler than AHAs; reduce frequency if irritation occurs.
Polyhydroxy Acids (PHA) has an evidence score of 4/10 — emerging evidence based on 9 indexed studies. A gentler, next-generation family of exfoliating acids (gluconolactone, lactobionic acid) applied to the skin — a cosmetic, not ingested. Because PHA molecules are larger than AHAs like glycolic acid, they penetrate more slowly and irritate less, while adding humectant and antioxidant properties. The honest framing: in head-to-head trials PHAs deliver anti-aging benefits comparable to AHAs with notably better tolerability — their real, evidence-backed niche is gentleness for sensitive and rosacea-prone skin. But the efficacy evidence is thin, older (mostly 2004–2010), and heavily industry-originated; there are no large modern independent RCTs, and effects are modest and roughly match or slightly trail AHAs. Representative study: PMID 15002657.
The commonly studied dose of Polyhydroxy Acids (PHA) is Topical cosmetic only. PHAs (gluconolactone, lactobionic acid) are used in leave-on toners, serums, and creams applied to clean skin, typically building from a few times weekly to daily as tolerated; sunscreen is recommended. There is no oral or systemic dose — they are not ingested. This library does not provide an ingestion protocol.. Individual needs vary — start at the lower end of the range and adjust based on how you respond.
Timing is flexible for Polyhydroxy Acids (PHA) — consistent daily use matters more than the time of day. PHAs are leave-on exfoliants with no meal-timing relationship; gentler than AHAs, they can be used AM or PM, though daily sunscreen is recommended with any exfoliating acid.
Polyhydroxy Acids (PHA) is generally well-tolerated and considered safe for most healthy adults at recommended doses. Reported side effects are uncommon and include mild stinging or dryness. Use caution if any of these apply to you: For topical (skin) use only — not for ingestion, not for injection; Known allergy or sensitivity to the formulation; Active dermatitis or broken/sunburned skin until healed.
Collagen
Likely helpsHydrolyzed peptides that rebuild skin elasticity, reduce joint pain, and strengthen bone density — results build over 8-12 weeks.
Sunscreen (SPF)
Mostly mechanism / observationalDaily broad-spectrum sunscreen — the single most evidence-based anti-aging skincare step there is, and the one most 'anti-aging' actives are really just trying to compensate for. The honest framing: this is the only topical on this list backed by a proper randomized controlled trial for skin aging itself. In the landmark Hughes 2013 trial (n=903), people randomized to daily sunscreen showed 24% less photoaging over 4.5 years — and no detectable increase in skin aging at all — while the mechanism (UV → matrix-metalloproteinase activation → collagen breakdown) is textbook. The same trial cohort also had less skin cancer. The honest caveats: the benefit is overwhelmingly prevention, not reversal of existing damage; real-world results depend entirely on applying enough and reapplying; and chemical (organic) UV filters are systemically absorbed above an FDA testing threshold (clinical significance unknown — mineral zinc-oxide/titanium-dioxide filters sidestep this). If you do one thing for your skin, it's this.
Tretinoin (Retin-A)
Mostly mechanism / observationalA prescription TOPICAL retinoid (Retin-A, Renova) — the acid form of vitamin A and the gold-standard, best-evidenced topical treatment for photoaging and acne. Multiple double-blind RCTs show it reduces fine wrinkles, mottled hyperpigmentation, and roughness over months, with histologic increases in dermal collagen. Caveats: retinoid dermatitis (irritation, peeling, dryness), photosensitivity, and it is CONTRAINDICATED IN PREGNANCY. Prescription drug, not a supplement; distinct from weaker OTC 'retinol' cosmetics.
Ceramides (topical)
Mostly mechanism / observationalBarrier-repair skincare applied to the skin — ceramide-containing moisturizers, NOT (in this context) oral ceramide supplements. Ceramides are the lipids that, with cholesterol and fatty acids, form the skin's water-proofing 'mortar.' These lipids are genuinely depleted in dry, aging, and atopic (eczema-prone) skin, so replacing them topically has a sound rationale. The honest framing: ceramide creams reliably lower water loss, raise hydration, and reduce eczema flares — but head-to-head trials show no consistent advantage over a good basic moisturizer (plain petrolatum, or a hyaluronic-acid foam), so most of the benefit is the moisturizing itself, with the ceramide a plausible-but-unproven upgrade. They are very well tolerated. These are skin-barrier/appearance outcomes, not health outcomes.
Explore: Best supplements for Skin, Hair & Beauty
Reviewed by Dr. Baher Al Hakim · Last reviewed June 2026 · evidence from 9 studies · how we score · editorial policy
This information is for educational purposes only. It is not a substitute for professional medical advice. Always consult a qualified healthcare provider before starting, stopping, or changing any supplement or medication.